Ghazi A. Bamagous
Mecca, Saudi Arabia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Correction: Synthesis of novel phenoxyacetohydrazide compounds and evaluation therapeutic potential exhibit as anti-inflammatory and anti-angiogenic.
Journal: PloS one
Published: December 18, 2025
Metabolomics-guided network pharmacology and molecular modeling suggest bioactive components of Chiliadenus montanus associated with multi-target anticancer and anti-inflammatory activities.
Journal: Medical oncology (Northwood, London, England)
Published: November 20, 2025
Integrative Metabolomic, Network Pharmacology, and Experimental Evidence for Lepidium sativum Seed Extract as a Natural Modulator of Pulmonary Fibrosis via the ncNRFR/Let-7d Regulatory Pathway.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: October 25, 2025
Synthesis of novel phenoxyacetohydrazide compounds and evaluation therapeutic potential exhibit as anti-inflammatory and anti-angiogenic.
Journal: PloS one
Published: June 13, 2025
Abnormalities in Blood Parameters in Athletes Taking Anabolic Androgenic Steroidal Agents; an Observational Clinical Study.
Journal: Substance abuse and rehabilitation
Published: October 03, 2024
A Recent Advance in the Diagnosis, Treatment, and Vaccine Development for Human Schistosomiasis.
Journal: Tropical medicine and infectious disease
Published: August 28, 2024
Deciphering the therapeutic potential of trimetazidine in rheumatoid arthritis via targeting mi-RNA128a, TLR4 signaling pathway, and adenosine-induced FADD-microvesicular shedding: In vivo and in silico study.
Journal: Frontiers in pharmacology
Published: March 25, 2024
Revolutionizing and identifying novel drug targets in Citrobacter koseri via subtractive proteomics and development of a multi-epitope vaccine using reverse vaccinology and immuno-informatics.
Journal: Journal of biomolecular structure & dynamics
Published: February 26, 2024
Trimetazidine Alleviates Bleomycin-Induced Pulmonary Fibrosis by Targeting the Long Noncoding RNA CBR3-AS1-Mediated miRNA-29 and Resistin-Like Molecule alpha 1: Deciphering a Novel Trifecta Role of LncRNA CBR3-AS1/miRNA-29/FIZZ1 Axis in Lung Fibrosis.
Journal: Drug design, development and therapy
Published: February 09, 2024
Last Updated: 09/26/2026